Updated

Supernus Pharmaceuticals and Apogee Enterprises each filed a Form 8-K current report with the U.S. Securities and Exchange Commission on November 2, 2026, according to EDGAR notices. The EDGAR feed carried no content for either filing, so the subject of each report is not described here. Form 8-K reports are used to disclose material events such as agreements, earnings or leadership changes.